These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18806690)

  • 21. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of ATP-sensitive potassium channels on 6-hydroxydopamine and haloperidol rat models of Parkinson's disease: implications for treating Parkinson's disease?
    Wang S; Hu LF; Yang Y; Ding JH; Hu G
    Neuropharmacology; 2005 Jun; 48(7):984-92. PubMed ID: 15857625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease.
    Crotty S; Fitzgerald P; Tuohy E; Harris DM; Fisher A; Mandel A; Bolton AE; Sullivan AM; Nolan Y
    Eur J Neurosci; 2008 Jan; 27(2):294-300. PubMed ID: 18190522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.
    El Arfani A; Albertini G; Bentea E; Demuyser T; Van Eeckhaut A; Smolders I; Massie A
    Neurochem Int; 2015 Sep; 88():88-96. PubMed ID: 26172319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic changes of striatal dopamine D2 receptor binding at later stages after unilateral lesions of the medial forebrain bundle in Parkinsonian rat models.
    Sun W; Sugiyama K; Asakawa T; Yamaguchi H; Akamine S; Ouchi Y; Magata Y; Namba H
    Neurosci Lett; 2011 Jun; 496(3):157-62. PubMed ID: 21514359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
    Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain.
    Thompson LH; Grealish S; Kirik D; Björklund A
    Eur J Neurosci; 2009 Aug; 30(4):625-38. PubMed ID: 19674082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats.
    Marin C; Aguilar E; Mengod G; Cortés R; Obeso JA
    Eur J Neurosci; 2009 Sep; 30(5):823-32. PubMed ID: 19712101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase of GAP-43 in the rat cerebellum following unilateral striatal 6-OHDA lesion.
    Perović M; Mladenović A; Rakić L; Ruzdijić S; Kanazir S
    Synapse; 2005 Jun; 56(3):170-4. PubMed ID: 15765516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nigrostriatal damage with 6-OHDA: validation of routinely applied procedures.
    Fulceri F; Biagioni F; Lenzi P; Falleni A; Gesi M; Ruggieri S; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():344-8. PubMed ID: 17105931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations of second messenger systems in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Tanji H; Kato H; Mizugaki M; Itoyama Y
    Eur J Pharm Sci; 1999 Aug; 8(4):261-7. PubMed ID: 10425376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary restriction does not prevent nigrostriatal degeneration in the 6-hydroxydopamine model of Parkinson's disease.
    Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
    Exp Neurol; 2008 Aug; 212(2):548-51. PubMed ID: 18508049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
    Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
    J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of the cystine/glutamate exchanger and the excitatory amino acid transporters in the rat lens.
    Lim J; Lam YC; Kistler J; Donaldson PJ
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2869-77. PubMed ID: 16043861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats.
    Gonzalez-Barrios JA; Lindahl M; Bannon MJ; Anaya-Martínez V; Flores G; Navarro-Quiroga I; Trudeau LE; Aceves J; Martinez-Arguelles DB; Garcia-Villegas R; Jiménez I; Segovia J; Martinez-Fong D
    Mol Ther; 2006 Dec; 14(6):857-65. PubMed ID: 17015039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of Fos and Zif268 in the nigrostriatal system after methamphetamine administration in a rat model of Parkinson's disease.
    Ishida Y; Kawai K; Magata Y; Ebihara K; Takeda R; Abe H; Yoshimoto M; Hashiguchi H; Odagiri K; Matsuo H; Nishimori T
    Synapse; 2008 Dec; 62(12):920-6. PubMed ID: 18792992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
    Fu Y; Ito M; Fujita Y; Ito M; Ichihara M; Masuda A; Suzuki Y; Maesawa S; Kajita Y; Hirayama M; Ohsawa I; Ohta S; Ohno K
    Neurosci Lett; 2009 Apr; 453(2):81-5. PubMed ID: 19356598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL; Kelly AM; Kennedy GA
    Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions.
    Truong L; Allbutt HN; Coster MJ; Kassiou M; Henderson JM
    Brain Res Bull; 2009 Feb; 78(2-3):91-6. PubMed ID: 19007866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats.
    Zhu Qf; Ma J; Yu Ll; Yuan Cg
    Neurosci Lett; 2009 Oct; 462(3):213-8. PubMed ID: 19596403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.